Home/Filings/4/0001123292-19-000166
4//SEC Filing

Farmer Joseph L 4

Accession 0001123292-19-000166

CIK 0001491576other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 9:56 AM ET

Size

24.3 KB

Accession

0001123292-19-000166

Insider Transaction Report

Form 4
Period: 2019-01-22
Farmer Joseph L
SVP, GC and Secretary
Transactions
  • Disposition from Tender

    Common Stock

    2019-01-22$75.00/sh9,367$702,5250 total
  • Disposition to Issuer

    Restricted Stock Units

    2019-01-221,2500 total
    Common Stock (1,250 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2019-01-2218,1820 total
    Common Stock (18,182 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-01-2275,0000 total
    Exercise: $57.66Exp: 2025-03-30Common Stock (75,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-01-2235,0000 total
    Exercise: $43.39Exp: 2026-03-01Common Stock (35,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-01-2231,9540 total
    Exercise: $55.84Exp: 2028-03-01Common Stock (31,954 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2019-01-228,7500 total
    Common Stock (8,750 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2019-01-224,4470 total
    Common Stock (4,447 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-01-2210,7820 total
    Exercise: $178.95Exp: 2027-03-01Common Stock (10,782 underlying)
Footnotes (6)
  • [F1]Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation ("Purchaser") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales ("Parent"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation ("TESARO"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the "Merger Agreement").
  • [F2]This number includes shares of TESARO common stock purchased under the TESARO, Inc. 2012 Employee Stock Purchase Plan.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of TESARO common stock.
  • [F4]These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share.
  • [F5]Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]
  • [F6][Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option.

Issuer

TESARO, Inc.

CIK 0001491576

Entity typeother

Related Parties

1
  • filerCIK 0001317757

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 9:56 AM ET
Size
24.3 KB